DiaMedica Therapeutics
DMAC • NASDAQ
DiaMedica Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Dietrich John Pauls, with a market cap of $353.6M.
CEODietrich John Pauls
Next Earnings
Upcoming earnings announcement for DiaMedica Therapeutics
Date
Tuesday, May 12, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.19
Earnings History
Past 11 earnings reports for DiaMedica Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 12, 2025 | Q3 2025 | -$0.17Est: -$0.16 | -6.3% | - | — |  10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.18Est: -$0.19 | +5.3% | - | — | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.18Est: -$0.18 | 0.0% | - | — | 10-Q |
| Mar 17, 2025 | Q4 2024 | -$0.18Est: -$0.17 | -5.9% | - | — | 10-K |
| Nov 13, 2024 | Q3 2024 | -$0.15Est: -$0.15 | 0.0% | - | — | 10-Q |
| Aug 7, 2024 | Q2 2024 | -$0.13Est: -$0.16 | +18.8% | - | — | 10-Q |
| May 8, 2024 | Q1 2024 | -$0.14Est: -$0.16 | +12.5% | - | — | 10-Q |
| Mar 19, 2024 | Q4 2023 | -$0.14Est: -$0.14 | 0.0% | - | — | 10-K |
| Nov 13, 2023 | Q3 2023 | -$0.12Est: -$0.13 | +7.7% | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$0.16Est: -$0.18 | +11.1% | - | — | 10-Q |
| May 15, 2023 | Q1 2023 | -$0.20Est: -$0.16 | -25.0% | - | — | 10-Q |